APOC2 and metabolic syndrome: The lipoprotein profiles shown in Fig. 2D-F suggest that the apoc2 mutant zebrafish are suitable for modeling human dyslipidemia, and the zebrafish model favorably compares with a large number of other models, including the Ldlr−/− mouse, as profiled previously (Yin et al., 2012).